These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 21538458)

  • 21. Glycosphingolipid structural analysis and glycosphingolipidomics.
    Levery SB
    Methods Enzymol; 2005; 405():300-69. PubMed ID: 16413319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics.
    Gika HG; Theodoridis GA; Plumb RS; Wilson ID
    J Pharm Biomed Anal; 2014 Jan; 87():12-25. PubMed ID: 23916607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Integration of metabonomics technology and its application in modernization of traditional Chinese medicine].
    Zhu C; Hu P; Liang QL; Wang YM; Luo GA
    Yao Xue Xue Bao; 2008 Jul; 43(7):683-9. PubMed ID: 18819470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted metabolomics for biomarker discovery.
    Griffiths WJ; Koal T; Wang Y; Kohl M; Enot DP; Deigner HP
    Angew Chem Int Ed Engl; 2010 Jul; 49(32):5426-45. PubMed ID: 20629054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabonomics: a useful tool for the future surgeon.
    Goldsmith P; Fenton H; Morris-Stiff G; Ahmad N; Fisher J; Prasad KR
    J Surg Res; 2010 May; 160(1):122-32. PubMed ID: 19592031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach.
    Alberice JV; Amaral AF; Armitage EG; Lorente JA; Algaba F; Carrilho E; Márquez M; García A; Malats N; Barbas C
    J Chromatogr A; 2013 Nov; 1318():163-70. PubMed ID: 24139504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ambient ionization mass spectrometry: current understanding of mechanistic theory; analytical performance and application areas.
    Weston DJ
    Analyst; 2010 Apr; 135(4):661-8. PubMed ID: 20309440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Status of mass spectrometry-based proteomics and metabolomics in basic and translational research.
    Kelleher NL
    Biochemistry; 2013 Jun; 52(22):3794-6. PubMed ID: 23614658
    [No Abstract]   [Full Text] [Related]  

  • 29. A review of clinical diagnostic applications of liquid chromatography-tandem mass spectrometry.
    Shushan B
    Mass Spectrom Rev; 2010; 29(6):930-44. PubMed ID: 20949635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated comparison of drug-related and drug-induced ultra performance liquid chromatography/mass spectrometry metabonomic profiles using human hepatocyte cultures.
    Croixmarie V; Umbdenstock T; Cloarec O; Moreau A; Pascussi JM; Boursier-Neyret C; Walther B
    Anal Chem; 2009 Aug; 81(15):6061-9. PubMed ID: 19588937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquid chromatography-tandem mass spectrometry-based plasma metabonomics delineate the effect of metabolites' stability on reliability of potential biomarkers.
    Yang W; Chen Y; Xi C; Zhang R; Song Y; Zhan Q; Bi X; Abliz Z
    Anal Chem; 2013 Mar; 85(5):2606-10. PubMed ID: 23387999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass spectrometry-based technologies for high-throughput metabolomics.
    Han J; Datla R; Chan S; Borchers CH
    Bioanalysis; 2009 Dec; 1(9):1665-84. PubMed ID: 21083110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mass spectrometry for the identification of the discriminating signals from metabolomics: current status and future trends.
    Werner E; Heilier JF; Ducruix C; Ezan E; Junot C; Tabet JC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(2):143-63. PubMed ID: 18672410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection Technologies. Ambient mass spectrometry.
    Cooks RG; Ouyang Z; Takats Z; Wiseman JM
    Science; 2006 Mar; 311(5767):1566-70. PubMed ID: 16543450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass spectrometry: from proteomics to metabolomics and lipidomics.
    Griffiths WJ; Wang Y
    Chem Soc Rev; 2009 Jul; 38(7):1882-96. PubMed ID: 19551169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gas chromatography coupled to mass spectrometry-based metabolomic to screen for anabolic practices in cattle: identification of 5α-androst-2-en-17-one as new biomarker of 4-androstenedione misuse.
    Anizan S; Bichon E; Duval T; Monteau F; Cesbron N; Antignac JP; Le Bizec B
    J Mass Spectrom; 2012 Jan; 47(1):131-40. PubMed ID: 22282099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gas chromatography/time-of-flight mass spectrometry based metabonomic approach to differentiating hypertension- and age-related metabolic variation in spontaneously hypertensive rats.
    Lu Y; A J; Wang G; Hao H; Huang Q; Yan B; Zha W; Gu S; Ren H; Zhang Y; Fan X; Zhang M; Hao K
    Rapid Commun Mass Spectrom; 2008 Sep; 22(18):2882-8. PubMed ID: 18720470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CE-TOF/MS: fundamental concepts, instrumental considerations and applications.
    Staub A; Schappler J; Rudaz S; Veuthey JL
    Electrophoresis; 2009 May; 30(10):1610-23. PubMed ID: 19441039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomics and metabolomics and their application to analgesia research.
    Reisdorph NA; Reisdorph R
    Methods Mol Biol; 2010; 617():457-73. PubMed ID: 20336441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary investigation of glycosylated proteins by capillary electrophoresis and capillary electrophoresis/mass spectrometry using electrospray ionization and by matrix-assisted laser desorption ionization/time-to-flight mass spectrometry.
    Bonfichi R; Sottani C; Colombo L; Coutant JE; Riva E; Zanette D
    Rapid Commun Mass Spectrom; 1995; Spec No():S95-106. PubMed ID: 8829487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.